Try our beta test site

TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Yale University
Information provided by (Responsible Party):
Cavion LLC
ClinicalTrials.gov Identifier:
NCT02202993
First received: July 15, 2014
Last updated: January 9, 2017
Last verified: January 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)